Representative publications - Cellular Haemostasis Group

  • Fejes Z, Póliska S, Czimmerer Z, Káplár M, Penyige A, Gál Szabó G, Beke Debreceni I, Kunapuli SP, Kappelmayer J, Nagy B Jr. Hyperglycemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost. 2016 Dec 15. [Epub ahead of print]
     
  • Nagy B Jr, Nagy B, Fila L, Clarke LA, Gönczy F, Bede O, Nagy D, Újhelyi R, Szabó Á, Anghelyi A, Major M, Bene Z, Fejes Z, Antal-Szalmás P, Bhattoa HP, Balla G, Kappelmayer J, Amaral MD, Macek M Jr, Balogh I. Human Epididymis Protein 4: A Novel Serum Inflammatory Biomarker in Cystic Fibrosis. Chest. 2016 Sep;150(3):661-72.
     
  • Szük T, Fejes Z, Debreceni IB, Kerényi A, Édes I, Kappelmayer J, Nagy B Jr. Integrity® bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience® everolimus-eluting stents in stable angina patients. Platelets. 2016 Jul;27(5):410-9.
     
  • Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmás P, Clemetson KJ, Nagy B Jr. Distinct effects of Re- and S-forms of LPS on modulating platelet activation. J Thromb Haemost 2013, 11:775-778
     
  • Nagy V, Kolozsvari B, Balogh Z, Csutak A, Kasza M, Nagy B Jr, Kardos L, Berta A, Pfliegler G. Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2013, 251(3):917-922
     
  • Reményi G, Szász R, Debreceni IB, Szarvas M, Batár P, Nagy B Jr, Kappelmayer J, Udvardy M. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets 2012, Dec 5.
     
  • doi: 10.3109/09537104.2012.731112 (in press)
     
  • Nagy B Jr, Miszti-Blasius K, Kerényi A, Clemetson KJ, Kappelmayer J. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation. Curr Med Chem 2012, 19(4):518-531
     
  • Shemirani AH, Nagy B Jr, Takáts AT, Zsóri KS, András C, Kappelmayer J, Csiki Z. Increased mean platelet volume in primary Raynaud’s phenomenon. Platelets 2012, 23:312-316
     
  • Olah Z, Kerényi A, Kappelmayer J, Schlammadinger A, Razso K, Boda Z. Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure. Platelets 2012, 23:495-498
     
  • Csongrádi É, Nagy B Jr, Fulop T, Varga Z, Karányi Z, Magyar MT, Oláh L, Papp M, Facskó A, Kappelmayer J, Paragh G, Káplár M. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost 2011, 106:683-92
     
  • Nagy B Jr, Jianguo J, Ashby B, Reilly MP, Kunapuli SP. Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J Thromb Haemost 2011, 9:810-9
     
  • Miszti-Blasius K, Beke Debreceni I, Felszeghy S, Dezso B, Kappelmayer J. Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge. Thromb Res 2011, 127:228-234
     
  • Simon Z, Kiss A, Erdödi F, Setiadi H, Beke Debreceni I, Nagy B Jr, Kappelmayer J. Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets. Platelets 2010, 21:555-562
     
  • Bagoly Z, Fazakas F, Marosi A, Török O, Bereczky Z, Haramura G, Kappelmayer J, Muszbek L. Variant type Glanzmann thrombasthenia caused by homozygous 724R/X mutation in beta3 integrin. Thromb Res 2010, 125:427-431
     
  • Nagy B Jr, Szük T, Debreceni IB, Kappelmayer J. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets 2010, 21:147-151
     
  • Toth J, Kappelmayer J, Udvardy ML, Szanto T, Szarvas M, Rejto L, Soltesz P, Udvardy M, Harsfalvi J. Increased platelet glycoprotein Ib receptor number, enhanced platelet adhesion and severe cerebral ischaemia in a patient with polycythaemia vera. Platelets 2009, 20:282-287
     
  • Bynagari YS, Nagy B Jr, Tuluc F, Bhavaraju K, Kim S, Vijayan KV, Kunapuli SP. Mechanism of activation and functional role of protein kinase Ceta in human platelets. J Biol Chem 2009, 284:13413-13421
     
  • Chari R, Getz T, Nagy B Jr, Bhavaraju K, Mao Y, Bynagari YS, Murugappan S, Nakayama K, Kunapuli SP. Protein kinase C[delta] differentially regulates platelet functional responses. Arterioscler Thromb Vasc Biol 2009, 29:699-705
     
  • Nagy B Jr, Bhavaraju K, Getz T, Bynagari YS, Kim S, Kunapuli SP. Impaired activation of platelets lacking protein kinase C-theta isoform. Blood 2009, 113:2557-2567
     
  • Nagy B Jr, Simon Z, Bagoly Z, Muszbek L, Kappelmayer J. Binding of plasma factor XIII to thrombin-receptor activated human platelets. Thromb Haemost 2009, 101:83-89
     
  • Miner J, Xia L, Yago T, Kappelmayer J, Liu X, Klopocki AG, Shao B, McDaniel M, Setiadi H, Schmidtke D, McEver RP. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 2008, 112:2035-2045
     
  • Nagy B Jr, Csongrádi É, Bhattoa HP, Balogh I, Blaskó G, Paragh G, Kappelmayer J, Káplár M. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost 2007, 98:186-191
     
  • Szük T, Nagy B Jr, Bereczky Z, Köszegi Z, Édes I, Kappelmayer J. Effects of “ad hoc” clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets 2006, 17:344-346
     
  • Losonczy G, Rosenberg N, Kiss Cs, Kappelmayer J, Vereb G, Kerényi A, Balogh I, Muszbek L. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Thromb Haemost 2005, 93:904-909
     
  • Kerényi A, Soltész P, Veres K, Szegedi G, Muszbek L.  Monitoring platelet function by PFA-100 closure time measurements during thrombolytic therapy of patients with myocardial infarction. Thromb Res 2005, 116:139-144
     
  • Kappelmayer J, Nagy B Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004, 42:475-486

Frissítés dátuma: 2019.06.05.